Prospective Evaluation of the Effect of an Aminoglycoside Dosing Regimen on Rates of Observed Nephrotoxicity and Ototoxicity

作者: Michael J. Rybak , Betty J. Abate , S. Lena Kang , Michael J. Ruffing , Stephen A. Lerner

DOI: 10.1128/AAC.43.7.1549

关键词:

摘要: The nephrotoxicity and ototoxicity associated with once-daily versus twice-daily administration of aminoglycosides was assessed in patients suspected or proven gram-negative bacterial infections a randomized, double-blind clinical trial. Patients who received therapy for ≥72 h were evaluated toxicity. also concomitant antibiotics as deemed necessary treatment their infection. Plasma aminoglycoside concentrations, prospective dosage adjustment, serial audiologic renal status evaluations performed. probability occurrence nephrotoxic event its relationship to doses daily exposure served the main outcome measurement. One hundred twenty-three enrolled study, 83 receiving at least 72 h. For 74 plasma concentrations available analysis, formed group evaluable primary infectious diagnosis study bacteremia sepsis, respiratory infections, skin soft tissue urosepsis pyelonephritis. Of toxicity, 39 twice 35 once placebo 12 later. Nephrotoxicity occurred 6 (15.4%) 0 daily. schedule administration, use vancomycin, area under concentration-time curve (AUC) found be significant predictors by multivariate logistic regression analysis (P ≤ 0.001). time significantly influenced vancomycin Cox proportional hazards modeling 0.002). results demonstrate that both are on which is administered well vancomycin. Furthermore, this risk modulated AUC exposure. These data suggest has predictably lower causing than administration.

参考文章(46)
Laurie L. Briceland, Sandra L. Preston, Single Daily Dosing of Aminoglycosides Pharmacotherapy. ,vol. 15, pp. 297- 316 ,(1995) , 10.1002/J.1875-9114.1995.TB04368.X
Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580
Lisbeth Nordström, Häkan Ringbert, Stig Cronberg, Orjan Tjernström, Mats Walder, Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity Journal of Antimicrobial Chemotherapy. ,vol. 25, pp. 159- 173 ,(1990) , 10.1093/JAC/25.1.159
J.M. Prins, H.R. Buller, P. Speelman, E.J. Kuijper, R.A. Tange, Once versus thrice daily gentamicin in patients with serious infections The Lancet. ,vol. 341, pp. 335- 339 ,(1993) , 10.1016/0140-6736(93)90137-6
Stephen A. Lerner, Barbara A. Schmitt, Robert Seligsohn, Gregory J. Matz, Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin The American Journal of Medicine. ,vol. 80, pp. 98- 104 ,(1986) , 10.1016/0002-9343(86)90486-9
Michael J. Rybak, Steven C. Boike, Donald P. Levine, Steven R. Erickson, Clinical use and toxicity of high-dose tobramycin in patients with pseudomonal endocarditis Journal of Antimicrobial Chemotherapy. ,vol. 17, pp. 115- 120 ,(1986) , 10.1093/JAC/17.1.115
M. Barza, J. P. Ioannidis, J. C Cappelleri, J. Lau, Single or multiple daily doses of aminoglycosides: a meta- analysis BMJ. ,vol. 312, pp. 338- 345 ,(1996) , 10.1136/BMJ.312.7027.338
Paul Ellis Marik, Jeffrey Lipman, Sacha Kobilski, Juan Scribante, None, A prospective randomized study comparing once- versos twice-daily amikadn dosing in critically ill adult and paediatric patients Journal of Antimicrobial Chemotherapy. ,vol. 28, pp. 753- 764 ,(1991) , 10.1093/JAC/28.5.753
R. D. Moore, C. R. Smith, P. S. Lietman, The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. The Journal of Infectious Diseases. ,vol. 149, pp. 443- 448 ,(1984) , 10.1093/INFDIS/149.3.443